Holding(s) in Company

AI SummaryClose X

Mark H Dixon has notified SkinBioTherapeutics PLC on October 1, 2025, that his voting rights attached to shares crossed a threshold on September 9, 2025. The notification pertains to an acquisition of voting rights. Mark H Dixon, through Rock Nominees Limited, now holds 24,887,876 ordinary shares, representing 9.617% of the voting rights in the company. There is no previous notification applicable and no voting rights through financial instruments.

Disclaimer*

UK 100

Latest directors dealings